Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)-DP20-002, Natural Experiments of the Impact of Population-Targeted Policies To Prevent Type 2 Diabetes and Diabetes Complications; Amended Notice of Meeting, 8593 [2020-03018]
Download as PDF
<![CDATA[
Federal Register / Vol. 85, No. 31 / Friday, February 14, 2020 / Notices
FEDERAL RESERVE SYSTEM
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Formations of, Acquisitions by, and
Mergers of Bank Holding Companies
Centers for Disease Control and
Prevention
The companies listed in this notice
have applied to the Board for approval,
pursuant to the Bank Holding Company
Act of 1956 (12 U.S.C. 1841 et seq.)
(BHC Act), Regulation Y (12 CFR part
225), and all other applicable statutes
and regulations to become a bank
holding company and/or to acquire the
assets or the ownership of, control of, or
the power to vote shares of a bank or
bank holding company and all of the
banks and nonbanking companies
owned by the bank holding company,
including the companies listed below.
The applications listed below, as well
as other related filings required by the
Board, if any, are available for
immediate inspection at the Federal
Reserve Bank indicated. The
applications will also be available for
inspection at the offices of the Board of
Governors. Interested persons may
express their views in writing on the
standards enumerated in the BHC Act
(12 U.S.C. 1842(c)).
Comments regarding each of these
applications must be received at the
Reserve Bank indicated or the offices of
the Board of Governors, Ann E.
Misback, Secretary of the Board, 20th
Street and Constitution Avenue NW,
Washington, DC 20551–0001, not later
than March 17, 2020.
A. Federal Reserve Bank of Boston
(Prabal Chakrabarti, Senior Vice
President) 600 Atlantic Avenue, Boston,
Massachusetts 02210–2204. Comments
can also be sent electronically to
BOS.SRC.Applications.Comments@
bos.frb.org:
1. HB Holdings, MHC, Haverhill,
Massachusetts; to become a mutual
bank holding company upon the
conversion by Haverhill Bank,
Haverhill, Massachusetts, from mutual
to stock form.
Board of Governors of the Federal Reserve
System, February 11, 2020.
Yao-Chin Chao,
Assistant Secretary of the Board.
khammond on DSKJM1Z7X2PROD with NOTICES
[FR Doc. 2020–03029 Filed 2–13–20; 8:45 am]
BILLING CODE P
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP)—DP20–002,
Natural Experiments of the Impact of
Population-Targeted Policies To
Prevent Type 2 Diabetes and Diabetes
Complications; Amended Notice of
Meeting
Notice is hereby given of a change in
the meeting of the Disease, Disability,
and Injury Prevention and Control
Special Emphasis Panel (SEP)—DP20–
002, Natural Experiments of the Impact
of Population-Targeted Policies To
Prevent Type 2 Diabetes and Diabetes
Complications; April 7–9, 2020; 10:00
a.m.–6:00 p.m., (EDT), Teleconference,
which was published in the Federal
Register on Friday, January 10, 2020,
Volume 85, Number 7, pages 1316–
1317.
The meeting is being amended to
change the date and time to April 7–8,
2020, from 11:00 a.m.–6:00 p.m., EDT.
The meeting is closed to the public.
For Further Information Contact: Jaya
Raman Ph.D., Scientific Review Officer,
CDC, 4770 Buford Highway, Mailstop
F80, Atlanta, Georgia 30341, Telephone:
(770) 488–6511, kva5@cdc.gov.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2020–03018 Filed 2–13–20; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Announcement of Requirements and
Registration for the 2020 Million Hearts
Hypertension Control Challenge
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
AGENCY:
VerDate Sep<11>2014
16:56 Feb 13, 2020
Jkt 250001
PO 00000
Frm 00058
Fmt 4703
Sfmt 4703
ACTION:
8593
Notice.
The Centers for Disease
Control and Prevention (CDC) located
within the Department of Health and
Human Services (HHS) announces the
launch of the 2020 Million Hearts
Hypertension Control Challenge.
DATES: The Challenge will accept
applications from February 21, 2020
through April 6, 2020.
FOR FURTHER INFORMATION CONTACT:
Division for Heart Disease and Stroke
Prevention, National Center for Chronic
Disease Prevention and Health
Promotion, Centers for Disease Control
and Prevention, 4770 Buford Hwy NE,
Mailstop MS–S107–1, Chamblee, GA
30341, Telephone: 770–488–2424,
Email: millionhearts@cdc.gov; subject
line of email: Million Hearts
Hypertension Control Challenge;
Attention: Mary George.
SUPPLEMENTARY INFORMATION:
SUMMARY:
Background
Million Hearts is a national initiative
to prevent one million heart attacks and
strokes by 2022. In order to prevent one
million cardiovascular events (e.g., heart
attacks and strokes), we need to
decrease smoking, sodium consumption
and physical inactivity by 20%;
improve performance on quality of care
measures for appropriate aspirin use,
blood pressure control, cholesterol
management, and smoking cessation to
80%; and improve outcomes for priority
populations disproportionately
burdened by cardiovascular disease.
Over the last six years, we have seen
tremendous progress by providers and
health care systems that focus on
improving their performance in
controlling patients’ blood pressure.
Getting to 80% blood pressure control
would mean that 10 million more
Americans with hypertension would
have their blood pressure under control,
and be at substantially lower risk for
strokes, heart attacks, kidney failure,
and other related cardiovascular events.
For more information about the
initiative, visit https://
millionhearts.hhs.gov/. Million Hearts is
a registered trademark of the
Department of Health and Human
Services.
The challenge is an important way to
call attention to the need for improved
hypertension control, provides a
powerful motivation and target for
clinicians, and will improve
understanding of successful
implementation strategies at the health
system level. It will identify clinicians,
clinical practices, and health systems
that have exceptional rates of
E:\FR\FM\14FEN1.SGM
14FEN1
]]>Agencies
[Federal Register Volume 85, Number 31 (Friday, February 14, 2020)]
[Notices]
[Page 8593]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-03018]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Disease, Disability, and Injury Prevention and Control Special
Emphasis Panel (SEP)--DP20-002, Natural Experiments of the Impact of
Population-Targeted Policies To Prevent Type 2 Diabetes and Diabetes
Complications; Amended Notice of Meeting
Notice is hereby given of a change in the meeting of the Disease,
Disability, and Injury Prevention and Control Special Emphasis Panel
(SEP)--DP20-002, Natural Experiments of the Impact of Population-
Targeted Policies To Prevent Type 2 Diabetes and Diabetes
Complications; April 7-9, 2020; 10:00 a.m.-6:00 p.m., (EDT),
Teleconference, which was published in the Federal Register on Friday,
January 10, 2020, Volume 85, Number 7, pages 1316-1317.
The meeting is being amended to change the date and time to April
7-8, 2020, from 11:00 a.m.-6:00 p.m., EDT.
The meeting is closed to the public.
For Further Information Contact: Jaya Raman Ph.D., Scientific
Review Officer, CDC, 4770 Buford Highway, Mailstop F80, Atlanta,
Georgia 30341, Telephone: (770) 488-6511, [email protected].
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention and
the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2020-03018 Filed 2-13-20; 8:45 am]
BILLING CODE 4163-18-P
